Nonviral Gene Therapy Platform Delivers CRISPR/Cas9 to Tumors – Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News |
Nonviral Gene Therapy Platform Delivers CRISPR/Cas9 to Tumors
Genetic Engineering & Biotechnology News Recently, a nanoparticle-based system developed by scientists based at the University of California, Berkeley, scientists who used it to repair the Duchenne muscular dystrophy gene in a mouse model. In the current study, the focus was on delivering … Thermo-triggered release of a genome-editing machinery by modified gold nanoparticles for tumor therapy China Has Already Gene-Edited 86 People With CRISPR |
